Company intelligence / Profile preview

PinPoint Data Science

High Wycombe, Buckinghamshire, United Kingdompinpointdatascience.com ↗

Ownership: Private
Employees: ~49
Development stage: Other

Overview

The company’s flagship product, the PinPoint Test, uses machine learning to analyze blood analyte data combined with patient information to identify individuals at higher risk of cancer. This enables faster specialist referrals and aims to reduce diagnostic delays. The test has been developed in collaboration with NHS England and focuses on improving early detection rates for cancer.

Therapeutic areas: Oncology
Modalities: Device (diagnostic software)Artificial intelligence-based diagnostic tool
Industry: Digital Health Medical Devices

Partnerships

NHS England

Beyond the preview

Go deeper on PinPoint Data Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PinPoint Data Science.

Explore the full profile